Publishing Details
About This Podcast
Explore Statistics
Recent Episodes
S1E24 Preview: Bo Wiinberg on Bridging Research and Trials with Cell-Based Therapies
Are cell therapies the key to bridging the gap between discovery research and clinical trials? In the inaugural episode of the Bioprocessing Unfiltered podcast, Bo Wiinberg, chief business…
S1E23 Episode: 23 - An Industry Veteran’s Insight on Data Governance and Provenance
In this episode of Evaluating Biopharma, host Ben Locwin and Scott Endicott, executive leader of Healthcare Solutions Integration, talk about data governance and data provenance—why they matter and…
S1E22 Episode: 22 - Insider’s Advice for Starting, Growing, Exiting a Biotech
In this month’s episode of Evaluating Biopharma, host Ben Locwin and Chris Major, founder and partner of BioProcess360 Partners, discuss the best ways to start a company to address technology gaps,…
S1E21 Episode: 21 - How AI is Changing the Antibody R&D Game
In this month’s episode of Evaluating Biopharma, host Ben Locwin and Tony Arulanandam, SVP and head of R&D at Cytovia Therapeutics, discuss how AI is impacting the antibody R&D field, how…
S1E20 Episode: 20 - Optimal Talent Management in Biopharma with Mara Strandlund and Niamh Alix
In this month’s special episode of Evaluating Biopharma, host Ben Locwin interviews Mara Strandlund, chief people officer at National Resilience, and Niamh Alix, chief human resources officer at…
S1E19 Episode: 19 - The Critical Role of Starting Materials & Processes in Advanced Therapies
In this month’s episode of Evaluating Biopharma, host Ben Locwin and Joaquim Vives, head of production of advanced therapies at Banc de Sang i Teixits, discuss cell and gene therapies and what sets…
S1E18 Episode: 18 - Bispecific Antibodies: What Are They? How Do They Work? An Expert's Thoughts
In this episode of Evaluating Biopharma, host Ben Locwin speaks with Dr. Stefan Schmidt, CEO of evitria AG, about bispecific antibodies. Dr. Schmidt goes into detail about current trends (from a…
S1E17 Episode: 17 - Essential Program Management Considerations for Biopharma With Jamie Martin
In this episode of Evaluating Biopharma, host Ben Locwin and Jamie Martin, PMP, senior consultant at Black Diamond Networks, discuss the tips and tricks of successful program management. Martin…
S1E16 Episode: 16 - Brian Tham on Project Management and Continuous Improvement in Biopharma
In this episode of Evaluating Biopharma, host Ben Locwin speaks with Brian Tham, principal consultant at Peregrine Bio, LLC, on how various projects are run in the pharmaceutical industry, how to…
S1E15 Episode: 15 - Facing CMC Challenges in CDMO-Sponsor Relationships for Rare Disease Platforms with Nesredin Mussa
In this month’s episode of Evaluating Biopharma, host Ben Locwin speaks with Nesredin Mussa, PhD, president of Dynamica Biologics, about navigating the challenges of securing successful CDMO-sponsor…
S1E14 Episode: 14 - Strategies and Approaches for Process Intensification With Dr. Stefan Schmidt
rocess intensification can be an overwhelming experience. In this episode of Evaluating Biopharma, host Ben Locwin speaks with Dr. Stefan Schmidt, CEO of evitria AG, about strategies and approaches…
S1E13 Episode: 13 - Identifying Impurities In Gene Therapy With Santoshkumar Khatwani
In this episode of Evaluating Biopharma, host Ben Locwin speaks with Santoshkumar Khatwani, Director – Analytical Development, Late-Stage CMC Analytical Team Lead at Sangamo Therapeutics, about…
S1E12 Episode: 12 - The Risks and Rewards of Speed-to-IND Strategies With Susan Jones
What are some strategies that companies can use to get to IND filing quickly? In this brand new conversation, Evaluating Biopharma podcast host Ben Locwin discusses the risks and rewards of…
S1E11 Episode: 11 - Cell Therapy Strategies: Preparing for Commercial Manufacturing of an Autologous Cell Therapy
In this episode of Evaluating Biopharma, host Ben Locwin, Vice President of Project Solutions at Black Diamond Networks, speaks with Jonathan Tsang, Senior Director, Manufacturing Sciences &…
S1E10 Episode: 10 - Gene Therapy Analytics: How to Make the Right CMC Investments for Your Business
In this episode of Evaluating Biopharma, Mike Kelly, Senior Vice President at Atsena Therapeutics, shares his experiences and provides his advice on how your company can make proper CMC investments…
S1E9 Episode: 9 - Gene Therapy Analytics: Identifying and Overcoming CMC Challenges in Gene Therapy
In this episode of Evaluating Biopharma, Ben Locwin, Vice President of Project Solutions at Black Diamond Networks, speaks with Susan D'Costa, Chief Technology Officer at Alcyone Therapeutics, who…
S1E8 Episode: 8 - The Financial Impact of a Continuous Bioprocessing Strategy
Joseph Shultz, VP and technical head of biologics and vaccines at Resilience, and John Bonham-Carter, board member and VP of business development and product management at Erbi Biosystems, discuss…
S1E7 Episode: 7 - Implementing an Efficient Allogeneic Cell Therapy Manufacturing Strategy
Marty Giedlin, vice president and head of technology operations at Senti Bio, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, to share his experiences…
S1E6 Episode: 06 - Process Intensification: PAT, AI, ML to Support Intensified Bioprocessing
Arthi Narayanan, innovation team leader of pharma technical operations at Genentech, and John Bonham-Carter, board member and VP of business development and product management at Erbi Biosystems,…
S1E5 Episode: 05 - Navigating Scale-Up Challenges in Protein Production
Parrish Galliher, an independent bioprocess consultant, speaks with moderator Ben Locwin, vice president of project solutions at Black Diamond Networks, about the context-dependent issues that arise…
Frequently Asked Questions
Evaluating Biopharma has published 25 episodes since September 2022, covering topics in Life Sciences, Science.
Evaluating Biopharma is currently declining with new episodes monthly. Average episode length is 21m.
